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Summary A case of primary myelofibrosis was identified with a previously unreported complex karyotype
with two abnormal clones in addition to a proportion of normal cells: 46,XY, - 2, - 11, + der(2)t(2; 1)
(q24/31;q13), + mar and 45,XY, - 2, - 11, + der(2)t(2;1 1)(q24/31;q13), + mar, - 17,del(7q). Study of circulating
committed progenitors from this patient consistently showed (1) an absence of erythroid progenitors which is
uncommon and (2) greatly increased granulocyte-monocyte progenitors (CFU-GM) which is generally
observed in myelofibrosis. Further study showed that peripheral blood mononuclear cells co-cultured with
irradiated normal bone marrow stroma generated increased numbers of CFU-GM compared with controls but
failed to generate erythroid progenitors, providing evidence for an intrinsic defect in erythropoiesis. Only once
previously has the absence of erythroid progenitors in primary myelofibrosis been studied in relation to
cytogenetic abnormalities. This case also revealed a complex karyotype which, however, shared with our case a
defect on chromosome 11. The identification of two cases of primary myelofibrosis which lack committed
erythroid progenitor cells and which show in common a chromosomal defect on chromosome 11 point to the
existence of genes on this chromosome which play a key role during erythropoiesis.
Primary myelofibrosis (PMF) is a form of chronic myelopro-
liferative disease characterised by bone marrow fibrosis,
hepatosplenomegaly and the presence of leucoerythroblastic
changes and tear drop poikilocytes in the peripheral blood.
The finding of G-6-PD isoenzyme restriction in patients'
peripheral blood cells, but not fibroblasts and the demonstra-
tion of clonal cytogenetic abnormalities in pluripotent
haemopoietic progenitor cells support the hypothesis that the
primary defect is a clonal expansion of pluripotent
haemopoietic progenitor cells associated with reactive mar-
row fibrosis (Jacobson et al., 1978; Ruutu et al., 1983; Sato et
al., 1986; Sugiyama et al., 1989). Reported cytogenetic aber-
rations have been varied but abnormalities of chromosome
13 have been the most common. (Borgstrom et al., 1984;
Johnson et al., 1985). PMF is also associated with extra-
medullary haemopoiesis and increased levels of circulating
haemopoietic progenitors including multilineage progenitors
(CFU-GEMM), megakaryocyte progenitors (CFU-Mk),
erythroid progenitors (BFU-E) and granulocyte-macrophage
progenitors (CFU-GM). Many cases have even shown ery-
thropoietin independent erythroid colony formation (Hibbin
et al., 1984; Carlo-Stella et al., 1987).
We report on a case of PMF in whom defective erythro-
poiesis, characterised by the absence of circulating erythroid
progenitors and the inability to generate erythroid colonies
on irradiated normal marrow stroma, was associated with a
complex cytogenetic abnormality. Comparison of the
karyotype in this case with that observed in a previously
reported case in whom erythropoiesis was defective (Partenen
et al., 1982) reveals a common abnormality involving
chromosome 11. The significance and possible linkage
between defective erythropoiesis and the karyotypic abnor-
mality is discussed.
Case report
A 71 year old man presented with anaemic symptoms, 8 cm
hepatomegaly and 12 cm splenomegaly. His Hb was 43 g I1',
Wbc 2.8 x 1091- with neutrophils 2.2 x 109 1' including
hypersegmented forms, lymphocytes 0.3 x 109 1-', monocytes
0.2 x 1091-', myelocytes <0.1 x 1091-', blasts 0.1 x 1091-',
normoblasts 1 per 100 w.b.c. and platelet count 95 x 109 1-'.
His blood film showed tear drop poikilocytes but infrequent
normoblasts which were rarely seen on subsequent blood
films. His reticulocyte count was 33 x 109 1` and both the
serum and red cell folate were reduced. Bone marrow aspira-
tion was unsuccessful and a trephine biopsy was hypercel-
lular showing marked granulocytic hyperplasia, absent
normoblasts, megakaryocytes of increased size with irregular
nuclei and increased reticulin fibrosis, consistent with features
in cases reported by Barosi et al., 1983. He was initially
supported with folic acid, allopurinol and blood transfusion
and was subsequently treated with hydroxyurea and oxy-
methalone. He remained transfusion dependent but after 7
months developed an increasing leukocyte count with an
increasing proportion of blast cells which was refractory to
therapy with hydroxyurea. He died 9 months after presenta-
tion having followed a course similar to patients reported by
Bentley et al., 1977.
Materials and methods
Cells
Peripheral blood mononuclear cells (PBMNC) from the
above case collected into preservative free heparin were
separated on ficoll-hypaque (Pharmacia, UK) and the inter-
face cells were washed three times in Iscove's modified
Dulbecco's medium (IMDM) (Gibco, UK).
Assaysfor CFU-GM and BFU-E
Fresh PBMNC were assayed for their ability to form colonies
in semi-solid medium using a method similar to that de-
scribed by Ash et al., 1981. For a CFU-GM assay, 2-8 x I04
PMF PBMNC were seeded in duplicate in a 1.0 ml volume
of IMDM containing 1.2% methylcellulose (Sigma), 20%
foetal calf serum (FCS, Gibco), 1% deionised bovine serum
albumin (Sigma), 5 x 10- M 2-mercaptoethanol (Sigma), 5%
phytohaemagglutinin stimulated leucocyte conditioned
medium (PHA-LCM) and 100 U ml' penicillin - 50Lg ml-'
streptomycin (Gibco). Colonies containing >40 cells were
enumerated at day 12. For assessment of BFU-E an identical
system containing erythropoietin (Eprex, Cilag UK) at
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3 U ml-' was used, the cells were plated at densities of
0.5-1.0 x Iml- m1 and the plates read after 14 days. Fresh
fractionated human foetal liver cells (Toksoz & Brown, 1984)
and normal bone marrow cells were used as positive controls.
The assays were performed on three different occasions,
firstly at diagnosis and on two other occasions when
hydroxyurea therapy had been stopped 96 h previously.
Initiation ofhaemopoiesis on irradiated stromafrom long term
bone marrow cultures
Fresh PBMNC were also tested for their ability to initiate
haematopoiesis on irradiated stroma from long term bone
marrow cultures (LTC). A 10 ml long term bone marrow
culture containing 2 x I07 marrow buffy coat cells from a
normal marrow donor was established and maintained in
medium as previously described (Gartner & Kaplan, 1980).
After 30 days nonadherent cells were removed, the adherent
cells trypsinised, irradiated with 15 Gray (Co 60 gamma rays,
mean energy 1.25 MeV, dose rate 5.3 Gy min-') and 3 ml of
cells at 1 x 105ml1' reseeded (i.e. at 3 x I04cm-2) in each of
three 35 mm diameter wells of a 6 well tissue culture plate
(Nunc). After 5 days incubation, during which a healthy
stroma had re-established, 1.5 ml of supernatant was
removed from each of the three wells and to each of two
wells was added 1.5 ml of LTC medium containing 5.4 x 106
fresh PMF PBMNC. To the remaining well was added 1.5 ml
LTC medium alone to act as a negative control. To each of
two other empty 35 mm diameter wells was added 5.4 x 106
fresh PMF PBMNC in 3 ml of LTC medium to act as a
PMF control. The five cultures were fed weekly by removing
half of the supernatant and replacing this with fresh LTC
medium. After 5 weeks all nonadherent cells were removed
and the cells in the adherent layer harvested by trypsinisa-
tion. Nonadherent and adherent cells were pooled, washed
and assayed for progenitor cells as described above. The total
number of cells harvested from each culture was as follows:
PMF PBMNC alone 11 x I05 and 14 x 105; co-cultures of
PBMNC and irradiated stroma 15 x 105 and 17 x 105; and
irradiated stroma alone 1.4 x I05cells. The cells in the
stroma alone culture were plated in duplicate at a density of
0.7 x 105 ml-' in an erythroid colony assay. Otherwise cells
from the other cultures were plated in triplicate in separate
assays for CFU-GM and BFU-E at densities ranging from
1.5 x 105-2.3 x 105ml-'.
Cytogenetic analysis
For analysis of peripheral blood cells, trypsin-Giemsa banded
slides were prepared from unstimulated cultures which after
24 h were treated with 0.02 ,ig ml-' colcemid for either 1 h or
24 h. Metaphases were analysed using standard chromosome
criteria. To demonstrate any cytogenetic abnormality in
CFU-GM isolated from our patient, pooled GM colonies
grown from PBMNC were harvested into IMDM containing
20% FCS and 10% phytohaemagglutinin-leucocyte condi-
tioned medium, and incubated overnight at 37°C in 5% CO2.
Colcemid was added and after I h and 24 h cells were
harvested and processed as described above.
Results
Cytogenetic analysis
Analysis of 20 metaphases from unstimulated cultures of
PBMNC showed three cell lines: one metaphase showed a
normal male karyotype; 13 cells showed 46 chromosomes
with the loss of one chromosome 2 and one 11, the presence
of an abnormal chromosome 2 derived from a 2;11 transloca-
tion and an additional unidentified marker chromosome
(46,XY, - 2, - 11,+ der(2)t(2;1 1)(q24/31;ql3),+ mar); and six
cells showed the above karyotype along with the loss of
one chromosome 17 and a deletion ofpart of the long arm of
one chromosome 7 (45,XY,- 2,-11,+ der(2)t(2;11Xq24/31;q13),
+ mar,- 17,del(7q)). Analysis of pooled GM colonies grown
from PBMNC showed the third karyotype described above in
8/10 metaphases. The other two metaphases described the
same karyotype with the addition of another unidentified
marker chromosome, implying some further clonal evolution
(Figure 1).
Colonyforming ability ofPBMNC
On three separate occasions culture of PBMNC revealed
greatly increased numbers of circulating CFU-GM with the
complete absence of erythroid colonies (Table I). The nature
of GM colonies was confirmed following staining of cytocen-
trifuged preparations of single colony contents. Positive con-
trol erythroid colonies were grown from fractionated human
foetal liver cells and from bone marrow cells.
Initiation ofhaemopoiesis on irradiatedstromafrom LTC
No GM or erythroid colonies were grown from the culture
containing irradiated allogeneic normal bone marrow stroma
alone and only GM colonies were grown in the other cultures
containing PMF PBMNC. Co-cultures containing both
irradiated stroma and PMF PBMNC yielded much greater
numbers of GM colonies than cultures containing PMF
PBMNC alone whether numbers were expressed in terms of
total CFU per culture or per 105 inoculating cells (Table II).
Rowanowsky stained cytospins ofcells taken from cultures at
the time of clonogenic assay did not show any cells of the
erythroid lineage.
Discussion
The main observations from this case study are the demon-
stration of absent circulating erythroid progenitors in PMF,
an uncommon event, and its association with a previously
unreported karyotypic abnormality.
Circulating haemopoietic progenitors, particularly CFU-
GM, are usually greatly increased in PMF. Studies of cir-
culating erythroid progenitors have shown normal or
increased levels in 18/18 cases studied by Carlo-Stella et al.,
1987, 17/18 cases studied by Partenen et al., 1982 and 2/2
cases studied by Douer et al., 1983. However, cases of PMF
have been reported in which erythroid progenitor cells are
absent. In the study of Hibbin and co-workers erythroid
progenitors were absent in four splenectomised patients (Hib-
bin et al., 1984) and Croizat et al., 1983 observed an absence
of erythroid progenitors in four patients, two of which had
been splenectomised. The absence of circulating erythroid
progenitors in PMF patients is not invariably linked to
splenectomy since the patient reported in this study and the
one identified by Partenen and co-workers with absent BFU-
E (Partenen et al., 1982) were not splenectomised. Further-
more, the two larger studies of 18 patients showed normal or
increased levels ofcirculating BFU-E in many splenectomised
patients (Partenen et al., 1982; Carlo-Stella et al., 1987).
Many observations support the fact that circulating com-
mitted progenitors in PMF largely arise from and circulate
from the spleen (Douay et al., 1987). Thus, in the patient
reported in this study the failure to detect circulating ery-
throid progenitors is due to either a defect in the capacity of
haemopoietic stem cells to undergo commitment to the ery-
throid lineage or the ability of committed erythroid
progenitors to undergo erythropoiesis or that erythroid pro-
genitors are generated and sequestered in the spleen.
An intrinsic defect in erythropoiesis is the most likely
explanation for the following reasons. Douay and co-workers
have shown that, in PMF patients, CFU-GM can be main-
tained in liquid suspension culture in the absence of a sub-
stantial stromal layer over a 10-week period and concluded
that primitive stem cells circulated in PMF patients (Douay
et al., 1987). In our study, PBMNC were co-cultured with
normal marrow stroma to maintain circulating primitive stem
cells and assess whether they were able to give rise to ery-130 W.N. PATTON et al.
19 . 20 : 21 22 K.................... :: m :.....: .:. :::. ............ar2
Figure 1 G-banded karyotype from the GM colony culture: 46,XY,-2,-11,+der(2)t(2;11)(q24/31;ql3),+marl,
- 17,del(7q), + mar2.
Table I Number of colony forming cells grown from PMF PBMNC and normal cells
PMF PBMNC Foetal Liver Bone marrow
CFUml-' of blood CFU per 105cells
Time point CFU-GM BFU-E/CFU-E CFU-GM BFU-E CFU-GM BFU-E
1 2,644 0 206 153 33 22
2 7,912 0 244 166 70 28
3 7,605 0 300 90 27 ND
ND = not done.
Table II Mean number (± s.e.m.) of CFU isolated after culture of PMF
PBMNC on irradiated bone marrow stroma
CFU-GM
Culture condition Per 105 cells Per total culture BFU-E/CFU-E
Stroma alone 0 0 0
PMF cells alone 14 (1.1), 11 (1.7) 156 (12), 101 (16) 0
PMF cells + stroma 27 (2.1), 20 (0.7) 405 (31), 348 (11) 0
throid progenitors in a normal and appropriate microen-
vironment. Erythroid progenitor cells were not generated and
the existence of circulating stem cells was supported by the
generation of increased numbers of CFU-GM following
incubation of PBMNC with marrow stroma as compared
with control PMF PBMNC cultured in the absence of
stroma. The failure to detect circulating erythroid progenitors
for technical reasons can be excluded since the assays were
controlled by the demonstration of erythroid progenitors in
appropriate numbers from foetal liver and from bone mar-
row cells.
Of those PMF patients previously studied with absent
circulating erythroid progenitors, cytogenetic data is available
for only one case which exhibited a complex karyotype -
47,XX,5q-.1 lq-,-20, + mar 1, + mar 2 (Partenen et al.,
1982). However, a common abnormality involving the long
arm of chromosome 11 between this and our case is of
interest and suggests a causal relationship between an abnor-
mality in the long arm of chromosome 11 and defective
erythropoiesis. An abnormality at 1lq13 has been reported
once previously in a case of PMF, though whether ery-
thropoiesis was defective in this case in unknown (Sessarego
et al., 1983). A review of the literature with regard to
oncogene associations at the relevant breakpoints in the caseERYTHROPOIESIS IN PMF WITH ABNORMAL 1 lq 131
reported in this study reveals that the proto-oncogene SEA
(S13 avian erythroblastosis oncogene homolog) maps to the
1 lql3 region (Williams et al., 1987; Nordenskjold et al.,
1989; Hayman et al., 1985). The involvement of this
oncogene should be explored at the molecular level.
In conclusion, the association between a distinct
cytogenetic abnormality on chromosome 11 and the absence
of committed erythryoid progenitor cells in PMF patients is
worthy of further study. Cytogenetic analysis of additional
patients with an absence of circulating erythroid progenitors
might reveal a common chromosome abnormality and point
to the location of genes which encode key intrinsic regulators
of erythoid lineage development. Furthermore, studies of
lesions in the generation of various committed progenitor
cells in PMF patients in relation to possible karyotypic
abnormalities offers a useful approach to the analysis of the
chromosomal location and organisation of genes which con-
trol the generation and differentiation of haemopoietic pro-
genitor cells.
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